Gamow Labs uses AI to turn genomic data and patient phenotypes into auditable clinical insights and treatment guidance.
Gamow Labs has raised $3.5M in total funding. The most recent round was Seed. The last funding was announced in August 2026.
Gamow Labs's investors include Scribble Ventures.
Gamow Labs is headquartered in Denver, United States.
Gamow Labs uses AI to turn genomic data and patient phenotypes into auditable clinical insights and treatment guidance.
Gamow Labs is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Gamow Labs — Funding & Investors." VCBacked, August 19, 2026, https://www.vcbacked.co/company/gamow-labs. Accessed September 3, 2026.
VCBacked. (2026). Gamow Labs — Funding & Investors. Retrieved September 3, 2026, from https://www.vcbacked.co/company/gamow-labs
{{cite web |title=Gamow Labs — Funding & Investors |url=https://www.vcbacked.co/company/gamow-labs |website=VCBacked |access-date=September 3, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated